目次

PrefaceThe first generation protease inhibitor Telaprevir and the emergence of antiviral resistanceFeatures of the second wave of the first generation protease inhibitors: effect and toleranceEffects and resistance risks of combination treatment with Daclatasvir + Asunaprevir: the first approved oral agent without IFN and ribavirinResistance features of NS5A inhibitors and methods for detectionDetection of naturally occurring variants with resistance features against antiviral drugsIncidence and characteristics of naturally occurring resistant strainsCharacteristics and resistance profiles of polymerase inhibitorsEmerging antivirals in the future